iRadimed (IRMD) vs SpyGlass Pharma (SGP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
iRadimed is the larger company by market cap ($1.04 billion vs $1.02 billion), about 1.0 times the size. iRadimed pays a dividend yielding 0.99%, while SpyGlass Pharma does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRMD | SGP |
|---|---|---|
| Share price | $81.02 | $30.43 |
| Market cap | $1.04B | $1.02B |
| 1-day change | -0.30% | -1.14% |
| YTD return | -16.71% | — |
| 1-year return | -9.50% | — |
| 5-year return | +91.58% | — |
| P/E ratio (TTM) | 43.33 | — |
| Forward P/E | 33.25 | — |
| EPS (TTM) | $1.87 | $-2.70 |
| Dividend yield | 0.99% | 0.00% |
| Annual dividend | $0.80 | $0.00 |
| Revenue (latest FY) | $83.81M | — |
| Revenue growth (YoY) | +14.43% | — |
| Net income (latest FY) | $22.48M | $-39.87M |
| Gross margin | 76.75% | — |
| Operating margin | 31.20% | — |
| Net margin | 26.82% | — |
| 52-week high | $107.90 | $39.92 |
| 52-week low | $76.35 | $17.06 |
| Distance from 52-week high | -24.91% | -23.77% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +45.64% | +53.37% |
| Average volume | 120.89K | 114.63K |
| Shares outstanding | 12.79M | 33.46M |
| Employees | 166 | 88 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
About SpyGlass Pharma
SGP stock →SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.
Health Care · Medical/Dental Instruments · 88 employees
IRMD vs SGP FAQ
Which is bigger, iRadimed or SpyGlass Pharma?
iRadimed (IRMD) is larger, with a market capitalization of $1.04B compared with $1.02B for SpyGlass Pharma (SGP).
Which pays a higher dividend, iRadimed or SpyGlass Pharma?
iRadimed pays a dividend yielding 0.99%, while SpyGlass Pharma does not currently pay a regular dividend.
Are iRadimed and SpyGlass Pharma in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.